文献速递乳房整形与再造美容整形

下一代测序表征乳房包膜挛缩微生物组

Characterizing the Microbiome of the Contracted Breast Capsule Using Next Generation Sequencing.
PubMed 文献 · Aesthet Surg J · 2021-01-01

本研究纳入32例隆乳术后Baker III或IV级包膜挛缩患者,对53个挛缩包膜组织及术中拭子行下一代测序。56%患者和42%样本检出微生物DNA,共鉴定120种细菌和6种真菌,最常见为大肠埃希菌(25%)。下一代测序可高分辨率刻画植入物周围微生物生态。

要点

  • 56%的包膜挛缩患者检出微生物DNA,提示微生物组可能参与包膜挛缩。
  • 共鉴定120种细菌和6种真菌,大肠埃希菌占所有分离株的25%。
  • 下一代测序较传统培养更全面揭示植入物周围微生物生态。

核心结论

  • 下一代测序可前所未有地详细表征乳房植入物周围的细菌生态系统,是理解微生物组在包膜挛缩中作用的关键一步。

研究设计与样本

  • 连续纳入32例美容性隆乳术后Baker III或IV级包膜挛缩患者,于包膜切除术中采集53个挛缩包膜组织及乳房包膜和植入物表面术中拭子,送MicroGenDX实验室行下一代测序。

主要发现

  • 32例患者中18例(56%)标本检出微生物DNA,53个样本中22个(42%)为阳性。
  • 测序共鉴定120种独特细菌和6种独特真菌;有微生物DNA的标本平均每人检出8.27(标准差4.8)种微生物。
  • 最常分离的物种为大肠埃希菌(占所有分离株25%)、Diaphorobacter nitroreducens(12%)、Cutibacterium acnes(12%)、表皮葡萄球菌(11%)、真菌物种(7%)和金黄色葡萄球菌(6%)。

临床怎么用

  • 对隆乳术后包膜挛缩患者,可考虑下一代测序评估包膜微生物组,以辅助理解病因。
  • 下一代测序结果可能指导未来针对特定微生物的干预研究,但当前尚不能直接改变临床处理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent work suggests that bacterial biofilms play a role in capsular contracture (CC). However, traditional culture techniques provide only a limited understanding of the bacterial communities present within the contracted breast. Next generation sequencing (NGS) represents an evolution of polymerase chain reaction technology that can sequence all DNA present in a given sample. OBJECTIVES: The aim of this study was to utilize NGS to characterize the bacterial microbiome of the capsule in patients with CC following cosmetic breast augmentation. METHODS: We evaluated 32 consecutive patients with Baker grade III or IV CC following augmentation mammoplasty. Specimens were obtained from all contracted breasts (n = 53) during capsulectomy. Tissue specimens from contracted capsules as well as intraoperative swabs of the breast capsule and implant surfaces were obtained. Samples were sent to MicroGenDX Laboratories (Lubbock, TX) for NGS. RESULTS: Specimens collected from 18 of 32 patients (56%) revealed the presence of microbial DNA. The total number of positive samples was 22 of 53 (42%). Sequencing identified a total of 120 unique bacterial species and 6 unique fungal species. Specimens with microbial DNA yielded a mean [standard deviation] of 8.27 [4.8] microbial species per patient. The most frequently isolated species were Escherichia coli (25% of all isolates), Diaphorobacter nitroreducens (12%), Cutibacterium acnes (12%), Staphylococcus epidermidis (11%), fungal species (7%), and Staphylococcus aureus (6%). CONCLUSIONS: NGS enables characterization of the bacterial ecosystem surrounding breast implants in unprecedented detail. This is a critical step towards understanding the role this microbiome plays in the development of CC.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Cook J, Holmes CJ, Wixtrom R, et al. Characterizing the Microbiome of the Contracted Breast Capsule Using Next Generation Sequencing. Aesthet Surg J. 2021. PMID: 32291435. doi:10.1093/asj/sjaa097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。